Innovating antibodies, improving lives

Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.


financial news 260x1732019 Full Year Financial Results

Genmab reported its 2019 Full Year financial results on February 19 and held an investor conference call to discuss the results.  Click here to listen to a replay of the webcast call; here to download the full Annual Report; here to download a Danish Summary of the Annual Report; here for an online summary of the report and; here to download the conference call slides. 


Investorportal sign on_260x173InvestorPortal

To register your email address for electronic shareholder communication or to update your settings, log on to the InvestorPortal.



join our team_260x173Career Opportunities at Genmab

Genmab is seeking new employees to join our team. Visit our Careers webpages to explore current vacancies, learn about our culture and meet some of our team members. Click here to visit Genmab's page on LinkedIn.    


Latest news

Our Strategy

  • Click here to watch a video about our strategy.

Strategy Film

Stock Info